Cincinnati Children's Secures $38.4 Million to Map Heart Disease Longevity

The new funding, extending through April 2032, marks the third cycle of federal investment in the Bench to Bassinet program. Having previously identified genetic causes for 25% of previously unexplained cases, the research team is shifting its mandate. Instead of focusing solely on initial enrollment, the program will now track participants over time to determine how specific genetic markers influence quality of life and future medical requirements.

Nicholas Ollberding, the project's contact principal investigator, noted that the funding allows researchers to evolve from initial discovery toward providing actionable data for families and clinicians. By linking genomic information with patient-reported outcomes and longitudinal clinical follow-ups, the team intends to clarify why heart defects manifest differently across patients. This shift is expected to move the field toward personalized care, helping doctors provide more precise counseling for the 40,000 infants born with congenital heart defects in the U.S. each year.

The administrative and data coordination efforts remain anchored at Cincinnati Children's, building on an existing database that includes whole-genome sequencing for more than 16,000 biosamples. Principal investigators James Cnota and Michael Wagner are spearheading the integration of this legacy data with new, modern infrastructure via the HeartsMart platform. This resource will be made available to investigators nationwide to accelerate the study of structural heart problems, ensuring that the diverse voices of the patient community inform the next decade of cardiovascular research.